Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;99(1):64-72.
doi: 10.1111/cen.14910. Epub 2023 Mar 20.

Tumour occurrence in women with Turner syndrome: A narrative review and single-centre case series

Shani A D Mathara Diddhenipothage  1 , Ryan J Goindoo  1 , Fiona Bragg  2   3 , Elizabeth Orchard  4 , Deborah Shears  5 , Matilde Calanchini  1 , Helen E Turner  1
Affiliations
Review

Tumour occurrence in women with Turner syndrome: A narrative review and single-centre case series

Shani A D Mathara Diddhenipothage et al. Clin Endocrinol (Oxf). 2023 Jul.

Abstract

Background: Population studies suggest cancer morbidity may be different in Turner syndrome (TS) compared to the background female population. However, significant variability is observed in cancer associations likely due to heterogeneity in patient cohorts. We explored the prevalence and patterns of cancer amongst a cohort of women with TS attending a dedicated TS clinic.

Methods: Retrospective analysis of the patient database was performed to identify TS women who developed cancer. Population data (available before 2015) from the National Cancer Registration and Analysis Service database were used for comparison.

Results: Out of 156 TS women, median age of 32 (range 18-73) years, 9 (5.8%) had a recorded cancer diagnosis. Types of cancers were, bilateral gonadoblastoma, type 1 gastric neuroendocrine tumour (NET), appendiceal-NET, gastrointestinal stromal tumour, plasma cell dyscrasia, synovial sarcoma, cervical cancer, medulloblastoma and aplastic anaemia. Median age at cancer diagnosis was 35 (range 7-58) years and two were detected incidentally. Five women had 45,X karyotype, three received growth hormone treatment and all except one received oestrogen replacement therapy. The cancer prevalence of the background age-matched female population was 4.4%.

Conclusions: We confirm the previous observations that women with TS do not appear to be at overall increased risk of common malignancies. Our small cohort showed a spectrum of rare malignancies that are not typically associated with TS, except for a single patient with a gonadoblastoma. The slightly higher prevalence of cancer in our cohort might simply represent increased cancer prevalence in the background population, or might be related to small sample size and regular monitoring of these women due to TS per se.

Keywords: cancer; sIngle-centre study; tumour; turner syndrome.

PubMed Disclaimer

References

REFERENCES

    1. Elsheikh M. Turner's syndrome in adulthood. Endocr Rev. 2002;23(1):120-140. doi:10.1210/er.23.1.120
    1. Ji J, Zöller B, Sundquist J, Sundquist K. Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: a national cohort study. Int J Cancer. 2016;139(4):754-758. doi:10.1002/ijc.30126
    1. Hasle H, Olsen J, Nielsen J, Hansen J, Friedrich U, Tommerup N. Occurrence of cancer in women with Turner syndrome. Br J Cancer. 1996;73(9):1156-1159. doi:10.1038/bjc.1996.222
    1. Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? the X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. BioEssays. 2011;33(11):791-802. doi:10.1002/bies.201100047
    1. Giat E, Ehrenfeld M, Shoenfeld Y. Cancer and autoimmune diseases. Autoimmun Rev. 2017;16(10):1049-1057. doi:10.1016/j.autrev.2017.07.022

LinkOut - more resources